Free Trial

Jasper Therapeutics (JSPR) Earnings Date, Estimates & Call Transcripts

Jasper Therapeutics logo
$5.51 +0.17 (+3.18%)
As of 01/17/2025 04:00 PM Eastern
Get Jasper Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jasper Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

JSPR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

JSPR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Jasper Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$1.48-$0.91-$1.20
Q2 20252-$1.63-$0.99-$1.31
Q3 20252-$1.78-$1.04-$1.41
Q4 20252-$1.93-$1.10-$1.52
FY 20258($6.82)($4.04)($5.43)

Jasper Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/3/2025
(Estimated)
-------
8/13/2024--$1.09-$0.97+$0.12-$0.97--
5/14/2024Q1 2024-$1.26-$1.03+$0.23-$1.03--
3/4/2024Q4 2023-$1.65-$1.50+$0.15-$1.50--
11/9/2023Q3 2023-$1.50-$1.60 -$0.10-$0.16--
8/11/2023Q2 2023-$1.30-$1.50 -$0.20-$0.15--
5/12/2023Q1 2023-$1.50-$1.60 -$0.10-$0.16--
3/8/2023Q4 2022-$3.70-$3.60+$0.10-$0.36--

Jasper Therapeutics Earnings - Frequently Asked Questions

Jasper Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates. Learn more on JSPR's earnings history.

Jasper Therapeutics (NASDAQ:JSPR) has a recorded net income of -$64.46 million. JSPR has generated -$4.74 earnings per share over the last four quarters.

Jasper Therapeutics's earnings are expected to decrease from ($4.47) per share to ($4.70) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:JSPR) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners